183 related articles for article (PubMed ID: 32565944)
1. Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis.
Yu T; Lu S; Xie W
Oncol Lett; 2020 Jul; 20(1):165-172. PubMed ID: 32565944
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of
Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
Front Genet; 2022; 13():959832. PubMed ID: 36299588
[No Abstract] [Full Text] [Related]
3. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
5. DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data.
Zhu C; Tong R; Jiang X; Xiao H; Guan J; Shu J
Front Genet; 2021; 12():767834. PubMed ID: 35265097
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
Zhu C; Xiao H; Jiang X; Tong R; Guan J
Front Genet; 2021; 12():819520. PubMed ID: 35173766
[No Abstract] [Full Text] [Related]
7. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
8. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
Front Oncol; 2021; 11():665192. PubMed ID: 34123827
[TBL] [Abstract][Full Text] [Related]
9. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma.
Yu B; Liang H; Ye Q; Wang Y
J Gastrointest Oncol; 2020 Oct; 11(5):1009-1023. PubMed ID: 33209494
[TBL] [Abstract][Full Text] [Related]
11. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
PeerJ; 2019; 7():e7816. PubMed ID: 31608178
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Wang Y; Huang Q; Deng T; Li BH; Ren XQ
Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
[TBL] [Abstract][Full Text] [Related]
13. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
Tang M; Liao M; Ai X; He G
Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
[TBL] [Abstract][Full Text] [Related]
14. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
Wei Z; Duan X; Li Q; Li Q; Wang Y
J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma.
Wei J; Liu Y; Zhao C
Front Oncol; 2021; 11():719973. PubMed ID: 34790567
[TBL] [Abstract][Full Text] [Related]
17. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
18. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
Gao J; Jia WD
Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
[TBL] [Abstract][Full Text] [Related]
19. Mediator complex subunit 8 is a prognostic biomarker in hepatocellular carcinoma.
Wu S; Li Q; Cao Y; Luo S; Wang Z; Zhang T
Am J Transl Res; 2022; 14(3):1765-1777. PubMed ID: 35422940
[TBL] [Abstract][Full Text] [Related]
20. Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma.
Fan Y; Hou J; Liu X; Han B; Meng Y; Liu B; Chen F; Shang Y; Cao P; Tan K
Front Genet; 2021; 12():668516. PubMed ID: 34917120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]